nivolumab,regorafenib
bms,bayer
[]
regorafenib appears to have a role in refractory gastroesophageal tumors. presented at #ascogi2023 #gi23 #gicancer #cancerresearch 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"